Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel LRRTM4-ALK fusion: a case report - Li, Bowen; Jia, Ziqi; Huang, Zhicheng; Xue, Jianchao; Wang, Yadong; Guo, Chao; Si, Xiaoyan; Chen, Zexin; Li, Ji; Chen, Rongrong; Bie, Zhixin; Giglio, Andrea De; et al. (Translational Lung Cancer Research, 2023)
Gesehen am 08.12.2023